Indinavir: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Indinavir}} | |||
{{CMG}}; {{AE}} {{MM}} | |||
==Overview== | |||
==Category== | |||
[[Protease inhibitor]] | |||
==US Brand Names== | |||
CRIXIVAN<sup>®</sup> | |||
==FDA Package Insert== | |||
'''[[Indinavir description|Description]]''' | |||
'''| [[Indinavir clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Indinavir microbiology|Microbiology]]''' | |||
'''| [[Indinavir indications and usage|Indications and Usage]]''' | |||
'''| [[Indinavir contraindications|Contraindications]]''' | |||
'''| [[Indinavir warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Indinavir adverse reactions|Adverse Reactions]]''' | |||
'''| [[Indinavir overdosage|Overdosage]]''' | |||
'''| [[Indinavir dosage and administration|Dosage and Administration]]''' | |||
'''| [[Indinavir how supplied|How Supplied]]''' | |||
==Mechanism of Action== | |||
Indinavir is an azapeptide HIV-1 protease inhibitor (PI). The compound selectively inhibits the virus-specific processing of viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = REYATAZ (Indinavir SULFATE) CAPSULE, GELATIN COATED [E.R. SQUIBB & SONS, L.L.C.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8#nlm34089-3 | publisher = | date = | accessdate}}</ref> | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 02:56, 8 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
CRIXIVAN®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied
Mechanism of Action
Indinavir is an azapeptide HIV-1 protease inhibitor (PI). The compound selectively inhibits the virus-specific processing of viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions.[1]
References
- ↑ "REYATAZ (Indinavir SULFATE) CAPSULE, GELATIN COATED [E.R. SQUIBB & SONS, L.L.C.]". Text " accessdate" ignored (help)